Journal of the American Heart Association
Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial
Trial in peopleBiomarkers
Papers by Jan M. Griffin
2 results
- AHA Scientific Sessions 2025 Abstract
Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study
Trial in peopleInterventions